Establishment Labs Holdings Inc (ESTA)
NASDAQ:ESTA
ESTA Stock Chart & Stats
$54.69
-$0.07(-0.15%)
At close: 4:00 PM EST
$54.69
-$0.07(-0.15%)
Day’s Range― - ―
52-Week Range$26.56 - $83.31
Previous CloseN/A
Volume125.18K
Average Volume (3M)510.67K
Market Cap
$1.60B
Enterprise Value$1.79B
Total Cash (Recent Filing)$75.57M
Total Debt (Recent Filing)$264.47M
Price to Earnings (P/E)―
Beta1.04
Next Earnings
May 11, 2026EPS Estimate
-0.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding29,320,847
10 Day Avg. Volume576,705
30 Day Avg. Volume510,665
Financial Highlights & Ratios
PEG Ratio0.99
Price to Book (P/B)91.68
Price to Sales (P/S)10.23
P/FCF Ratio-37.92
Enterprise Value/Market Cap1.12
Enterprise Value/Revenue8.49
Enterprise Value/Gross Profit12.25
Enterprise Value/Ebitda-71.08
Forecast
1Y Price Target
$89.00Price Target Upside62.74% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)-1.01
Revenue Forecast (FY)$264.60M
Bulls Say, Bears Say
Bulls Say
Product Pipeline And Regulatory ApprovalsApproval for the Ergo2 implant would enable launches of Mia and GEM in the U.S., expanding the portfolio and creating new revenue channels.
Profitability And Cash Flow OutlookBeating revenue and adjusted EBITDA expectations, wider gross margins, and management's plan to reach a positive cash flow quarter in 2026 support a path toward sustainable profitability.
U.S. Commercial TractionRapid U.S. adoption of Motiva and strong early-user feedback on Preservé are driving higher-than-expected U.S. sales and creating training sites that accelerate broader market uptake.
Bears Say
Channel Concentration RiskHeavy dependence on third-party distributors in China raises execution risk and could delay account onboarding, limiting volume growth in the market.
China Distribution ChallengesDistributor problems in China may slow adoption and reduce expected revenue contribution from that region, tempering international growth.
Earnings And Cash Flow SensitivityProlonged distributor disruptions in China could increase earnings volatility and pressure near-term cash flow if the region underperforms expectations.
Establishment Labs Holdings News
ESTA FAQ
What was Establishment Labs Holdings Inc’s price range in the past 12 months?
Establishment Labs Holdings Inc lowest stock price was $26.55 and its highest was $83.31 in the past 12 months.
What is Establishment Labs Holdings Inc’s market cap?
Establishment Labs Holdings Inc’s market cap is $1.60B.
When is Establishment Labs Holdings Inc’s upcoming earnings report date?
Establishment Labs Holdings Inc’s upcoming earnings report date is May 11, 2026 which is in 41 days.
How were Establishment Labs Holdings Inc’s earnings last quarter?
Establishment Labs Holdings Inc released its earnings results on Feb 24, 2026. The company reported -$0.09 earnings per share for the quarter, beating the consensus estimate of -$0.222 by $0.132.
Is Establishment Labs Holdings Inc overvalued?
According to Wall Street analysts Establishment Labs Holdings Inc’s price is currently Undervalued.
Does Establishment Labs Holdings Inc pay dividends?
Establishment Labs Holdings Inc does not currently pay dividends.
What is Establishment Labs Holdings Inc’s EPS estimate?
Establishment Labs Holdings Inc’s EPS estimate is -0.36.
How many shares outstanding does Establishment Labs Holdings Inc have?
Establishment Labs Holdings Inc has 29,320,847 shares outstanding.
What happened to Establishment Labs Holdings Inc’s price movement after its last earnings report?
Establishment Labs Holdings Inc reported an EPS of -$0.09 in its last earnings report, beating expectations of -$0.222. Following the earnings report the stock price went up 6.283%.
Which hedge fund is a major shareholder of Establishment Labs Holdings Inc?
Currently, no hedge funds are holding shares in ESTA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Establishment Labs Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$89.00 (62.74% Upside)
$89.00 (62.74% Upside)
Blogger Sentiment
Bullish
ESTA Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 199.0K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
91.47%
12-Months-Change
Fundamentals
Return on Equity
-201.79%
Trailing 12-Months
Asset Growth
2.98%
Trailing 12-Months
Company Description
Establishment Labs Holdings Inc
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
ESTA Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents strong positive momentum: robust revenue growth (Q4 +45.2%, FY +27.2%), expanding U.S. adoption and materially improved margins and adjusted EBITDA. Management provided constructive 2026 guidance (≈25% growth) and a path to full-year cash flow profitability in 2027, supported by product momentum (Motiva, Preserve, Mia) and a growing account base. Notable risks include China/distributor volatility, a reconstruction revenue cadence pushed to 2027, elevated operating expenses and refinancing considerations, and execution risk tied to rapid commercial expansion and a leadership transition. Overall, the positive operational and financial trends materially outweigh the listed challenges.View all ESTA earnings summariesESTA Stock 12 Month Forecast
Average Price Target
$89.00
▲(62.74% Upside)
Technical Analysis
Ownership Overview
19.68% Insiders
7.83% Mutual Funds
59.10% Other Institutional Investors
12.40% Public Companies and
Individual Investors